Physicians' Adoption of Pharmaceutical E-Detailing: Application of Rogers' Innovation-Diffusion Model

Determinants of Physicians' Purchase Intention for Innovative Services: Integrating Professional Characteristics With Technology Acceptance Model and Theory of Planned Behaviour

“…This confirms the view that younger physicians, who tend to be more innovative, are a more attractive target market for marketing managers. Even when they are not in a position to make a purchase decision, their colleagues will seriously take their opinion into account, as physicians have always relied on their peers' perceptions when deciding for an innovation adoption (Audet, Doty, Shamasdin and Schoenbaum, 2005;Alkhateeb, Khanfar and Loudon, 2010).…”

“…Contrary to Chau and Hu (2002a) who suggest that subjective norm has no significant effects on physicians' behavioural intention, there are various theoretical accounts of social pressures and network effects which lead us to believe that significant others' perceptions of physicians' professional image will have a significant influence on their behavioural intentions towards innovative products/services (Moore and Benbasat, 1991;Venkatesh and Davis, 2000;Alkhateeb, Khanfar and Loudon, 2010). Evidently, this emerges from the commonly accepted notion that the adoption of a high-tech innovative service or product acts as an effective signal of enhanced status and an indication of personal innovativeness (Wood and Hoeffler, 2012); this appears to be of paramount importance to physicians (Venkatesh and Davis, 2000;Yi et al, 2006;Nuq and Aubert, 2013).…”

“…Ford, McAlearney, Phillips, Menachemi and Rudolph, 2008). According to Alkhateeb, Khanfar and Loudon (2010), as physicians' years in practice increase, they become less eager to adopt new technologies. This implies a significant negative influence of work experience on purchase intention for innovative services, which is both direct and …”

The Evaluation Model for Interior Design Organizational Technology Integration: The quality of the design aid and economic evidence and factors

“…By understanding the principles and using them, organizational leaders can get their products in the marketplace and there may be a high probability that they may be adopted by the consumers. Basically, if decision makers can test the innovation without making a full commitment, doubt is reduced, and therefore, the possibility of acceptance rises [3].…”

Relación entre promoción farmacéutica y prescripción de medicamentos en Perú

“…Al revisar la literatura científica sobre la promoción farmacéutica, se encuentran diversas investigaciones sobre diferentes aspectos que implica la promoción farmacéutica, por ejemplo: la evolución incremental de los gastos que conlleva la promoción farmacéutica en la IF estadounidense (Gagnon & Lexchin, 2008;Narayanan, Desiraju, & Chintagunta, 2004;Spurling et al, 2010); la relación del médico con el visitador médico, la utilización de las muestras médicas y el rol promocional e informativo de estos tres componentes utilizados por la IF, para mantener e incrementar la generación de prescripción de medicamentos (Lieb & Scheurich, 2014;Mintzes et al, 2013;Mizik & Jacobson, 2004;Norris, Herxheimer, Lexchin, & Mansfield, 2005;Spurling et al, 2010); así mismo, la utilización de diversos regalos y cortesías hacia el médico para lograr las preferencias de utilización de ciertos medicamentos (Hoppel, 2009;Norris et al, 2005;Wazana, 2000); igualmente, la utilización de la capacitación médica continua para acercar la IF a los médicos que prescriben diversos (Alkhateeb, Khanfar, Doucette, & Loudon, 2010;Norris et al, 2005); también, el uso de la promoción farmacéutica virtual ( también llamada e-detailing) Gönül, Carter, Petrova, & Srinivasan, 2001;Ventura, Baybars, & Dedeoglu, 2012); finalmente, la existencia de los principios éticos, las regulaciones y normativas de la IF (Campbell et al, 2010;Kremer, Bijmolt, Leeflang, & Wieringa, 2008;Norris et al, 2005;Spurling et al, 2010;World Health Assembly, 1988).…”